Physician profile
Derek Letort
NPI 1023202272
$25,344.59
in general payments reported to CMS, 2019-2025
69 companies · $4,271 in 2025
The $4,271 reported for 2025 was more than what 83% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,790 · 2020: $2,223 · 2021: $2,640 · 2022: $3,404 · 2023: $3,734 · 2024: $4,282 · 2025: $4,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,287.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,828.59 | 2019-2025 | |
| Pfizer INC. | $1,338.47 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,194.37 | 2019-2025 | Austedo Xr, Ajovy, Austedo |
| Sk Life Science, INC. | $1,193.91 | 2020-2025 | Xcopri |
| Acadia Pharmaceuticals INC | $1,142.01 | 2019-2025 | Nuplazid |
| Ucb, INC. | $1,129.78 | 2019-2025 | Briviact, Nayzilam |
| Mdd US Operations, LLC | $1,037.44 | 2019-2025 | Gocovri, Apokyn, Xadago |
| Lundbeck LLC | $1,036.12 | 2019-2025 | Vyepti, Rexulti |
| Biogen, INC. | $969.81 | 2019-2025 | Leqembi, Skyclarys |
| Novartis Pharmaceuticals Corporation | $963.50 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $893.16 | 2019-2025 | Ultomiris |
| Neurocrine Biosciences, INC. | $841.40 | 2019-2025 | Ingrezza, Ongentys |
| Genzyme Corporation | $808.43 | 2019-2023 | |
| Lilly USA, LLC | $749.03 | 2019-2025 | Kisunla, Emgality, Amyvid |
| Acorda Therapeutics, INC | $632.21 | 2019-2024 | Inbrija |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $527.35 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Greenwich Biosciences, INC. | $501.62 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $479.11 | 2023-2025 | Nuedexta, Rexulti |
| Biohaven Pharmaceuticals, INC. | $459.97 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $458.62 | 2022 | |
| Merz Pharmaceuticals, LLC | $457.40 | 2023-2025 | Xeomin, Inbrija, Ampyra |
| Amgen INC. | $416.48 | 2019-2025 | Uplizna |
| Genentech USA, INC. | $399.25 | 2019-2022 | |
| Impel Pharmaceuticals INC. | $387.89 | 2022-2023 | Trudhesa |
| Allergan, INC. | $369.88 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $365.00 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $350.13 | 2019-2022 | |
| Upsher-Smith Laboratories LLC | $281.19 | 2019-2023 | |
| Emd Serono, INC. | $272.75 | 2019-2025 | |
| Catalyst Pharmaceuticals, INC. | $266.86 | 2021-2025 | Firdapse, Fycompa |
| Amneal Pharmaceuticals LLC | $262.47 | 2019-2025 | Rytary, Ongentys, Crexont |
| Adamas Pharmaceuticals, INC. | $259.15 | 2019-2020 | |
| Csl Behring | $226.75 | 2019-2025 | Hizentra |
| Grifols USA, LLC | $224.78 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $215.05 | 2023-2024 | Aptiom |
| Kyowa Kirin, INC. | $200.60 | 2020-2025 | Nourianz |
| Jazz Pharmaceuticals INC. | $174.66 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $164.52 | 2019-2022 | |
| Ge Healthcare | $164.17 | 2019-2022 | |
| Corium, LLC | $148.01 | 2022-2023 | Adlarity |
| Neurelis, INC. | $145.83 | 2023-2025 | Valtoco |
| Mallinckrodt Hospital Products INC. | $138.06 | 2021-2023 | Acthar |
| Eisai INC. | $112.05 | 2024-2025 | |
| Axsome Therapeutics, INC. | $89.15 | 2025 | Symbravo |
| Insightec,INC | $88.67 | 2025 | Exablate |
| Celgene Corporation | $79.54 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $79.06 | 2020 | |
| Amylyx Pharmaceuticals, INC. | $71.97 | 2023 | Relyvrio |
| Assertio Therapeutics, INC. | $63.51 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $62.07 | 2019 | |
| Livanova USA, INC. | $56.85 | 2019 | |
| Ani Pharmaceuticals, INC. | $56.30 | 2024 | Purified Cortrophin Gel |
| Horizon Therapeutics Plc | $51.75 | 2021-2023 | Uplizna |
| Supernus Pharmaceuticals, INC. | $48.23 | 2019-2020 | |
| Medtronic, INC. | $46.22 | 2022-2023 | Activa Pc |
| Alnylam Pharmaceuticals INC. | $42.20 | 2019-2025 | Amvuttra |
| Abbott Laboratories | $38.56 | 2021-2025 | Eterna |
| Janssen Biotech, INC. | $35.49 | 2025 | |
| Mylan Specialty L.P. | $32.88 | 2023 | Glatiramer Acetate |
| Piramal Critical Care | $32.10 | 2019 | |
| Arbor Pharmaceuticals, INC. | $30.52 | 2019-2020 | |
| Si-Bone, INC. | $24.49 | 2023 | |
| Akcea Therapeutics, INC. | $22.75 | 2019 | |
| Xeris Pharmaceuticals, INC. | $21.71 | 2024 | Keveyis |
| Janssen Pharmaceuticals, INC | $20.71 | 2022 | |
| Boston Scientific Corporation | $20.09 | 2025 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $15.17 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.16 | 2020 | |
| Philips North America LLC | $12.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Letort listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.